Tia Wheatley DNP, RN, AOCNS, BMTCN


Wheatley and Gopalsami Highlight the Value of Interdisciplinary Collaboration in HSCT Care

Tia Wheatley, DNP, RN, AOCNS, BMTCN, and Shivani Gopalsami, RN, MSN, ANP-BC, AOCNP, discuss the benefits and challenges of multidisciplinary collaboration in hematopoietic stem cell transplant care.

Elizabeth Boateng, MSN, RN, FNP-BC, OCN


Caring for an Immunocompromised Bone Marrow Transplant Recipient

Special protocols are required to ensure the safety of patients undergoing bone marrow transplants.

Mike Hennessy Jr


Questions of Accessibility and Inclusion Continue to Draw Attention in Oncology Nursing

No system can properly flourish without constant efforts to diversify, and the nursing field is no exception.

Todd Shryock


Older Patients Are Comfortable With Telehealth and Prefer It as an Option

92% of those over 70 say they are comfortable with telehealth.

Heather Niccum Haag, BSN, RN, CCRN


Heather Niccum Haag on Improving Patient Education With Belzutifan

Heather Niccum Haag, BSN, RN, CCRN, shares her experience creating an educational resource for her patients with Von-Hippel Lindau tumors who are receiving belzutifan.

Jason Astrin, DMSc, MBA, PA-C, DFAAPA


Advanced Practice Providers Are Uniquely Suited for Survivorship Care

Advanced practice providers are the future of survivorship care because of the tremendous value they offer to the practice and its patients.

Antonia DePace


Global Study Suggests More Informational Resources Needed for Renal Cell Carcinoma

A global study revealed that patients and caregivers alike reported insufficient knowledge surrounding renal cell carcinoma.

Jason Kiernan, PhD, RN, ACNP


Prescribing 20 mg of Mozart for Chemotherapy-Induced Nausea

A Michigan State University investigator is preparing to expand on an encouraging pilot study that used a music-listening intervention to influence chemotherapy-induced nausea.

Heather Simonsen, MA


5 Media Tips and Tricks For Health Care Professionals

Heather Simonsen, MA, outlines some ways for health care professionals to feel more comfortable in the spotlight.

Amanda Warner, MS, BSN, RN, OCN


Oncology Drug Crash Course: Teclistamab-cqyv (Tecvayli)

Amanda Warner, MS, BSN, RN, OCN, who is manager of research informatics & real world evidence with Florida Cancer Specialists & Research Institute, provides an in-depth look at teclistamab in a downloadable fact sheet.

Ian E. Krop, MD, PhD


Datopotamab Deruxtecan Demonstrates Manageable Safety Profile in TNBC

Compared with other antibody-drug conjugates, datopotamab deruxtecan was associated with lower rates of neutropenia, pneumonitis, and hematologic toxicity.

Mary Hanley, LMSW


Talking With Patients About Potential Cancer Misinformation

Oncology nurses can help their patients navigate misinformation that they may find online.

Image of Serenity Mirabito
Serenity Mirabito, MSN, RN, OCN


Top Executives Vow to Improve Health Disparities among Patients with Multiple Myeloma

Oncology nurses are often the main point of contact for newly diagnosed patients with cancer. We have the opportunity to ensure that each person starts their journey with equality and equity on their side.

Miranda Lankas


Chemotherapy Plus Endocrine Therapy Increases Cognitive Impairment in Breast Cancer

Patients with breast cancer may be at risk for more intense cognitive impairment following treatment with chemotherapy plus endocrine therapy.

Rosaleen Bloom PhD, APRN, ACNS-BC, AOCNS


Hilda Haynes-Lewis and Rosaleen Bloom on Financial Toxicity and Workplace Stressors for Patients Undergoing Radiation

Hilda Haynes-Lewis, PhD, ANP-BC, AOCNP; and Rosaleen Bloom PhD, APRN, ACNS-BC, AOCNS, discuss the ways a cancer diagnosis can impair an individual’s ability to work normally.

Dana-Farber Cancer Institute


Study suggests Lymphoma Patients With Depression or Anxiety Experience Shorter Survival Times

Patients with depression had a 37% higher risk of dying from their disease than patients without a mental health diagnosis.

Karmanos Cancer Institute


Karmanos nurse wins MDONS Outstanding Oncology Nurse of the Year Award

Agnes Pilecki, BSN, RN, a nurse on Barbara Ann Karmanos Cancer Institute’s bone marrow transplant unit, has been named the Metro Detroit Oncology Nursing Society’s (MDONS) Outstanding Oncology Nurse of the Year.

Michelle Fortier, PhD


Approach Health Disparities From All Angles

April is National Minority Health Month, highlighting the need for health care and community sectors to come together and improve cancer outcomes for underserved populations.

Reanne Booker, MN, NP


Reanne Booker on Factors to Consider When Discussing Palliative Radiation

Reanne Booker, MN, NP, highlights factors that make a patient a good candidate for palliative radiation.

Jessica Scruton, BSN, RN, CCM


Care Management Tools Can Mitigate Clinician Burnout

Although technology alone can’t solve clinician burnout, it can provide the means for organizations to provide better care while increasing efficiency and alleviating stress.

Paula Anastasia, RN, MN, AOCN


Paula Anastasia on PARP Inhibitor Ineligibility Factors for Women With Ovarian Cancer

Paula Anastasia, RN, MN, AOCN, highlights circumstances in which patients may not be eligible to receive benefit with a PARP inhibitor.

Morgan Bayer


Durvalumab Garners Similar OS, Albeit Varied PFS, Outcomes in EGFR+ and EGFR-Wildtype NSCLC Subgroups

Findings from the PACIFIC-R trial showed that patients with EGFR-mutated non-small cell lung cancer experienced shorter progression-free survival with durvalumab than patients with EGFR-wildtype disease.

Ashling Wahner


First-Line Immunotherapy Is Associated With Worse Survival Outcomes in Synchronous mRCC

Patients with synchronous metastatic renal cell carcinoma experienced worse outcomes with first line immune-checkpoint inhibitors-based combinations vs those with metachronous disease.

Aliènne Salleroli, MS, BSN, RN, OCN.


Aliènne Salleroli on Starting the DEI Conversation in Oncology Nursing

Aliènne Salleroli, MS, BSN, RN, OCN, underscores the importance of open dialogue surrounding diversity, equity, and inclusion in oncology leadership.

Michelle Mollica, PhD, MPH, RN, OCN


Michelle Mollica on Individualizing Care Plans for Cancer Survivors

Michelle Mollica, PhD, MPH, RN, OCN, of the National Cancer Institute, discusses how childhood cancer survivors may face different challenges than adult or geriatric patients.

Jennifer R. Green, MD


Bring A Nuanced Approach to Venous Thromboembolism Management

Understanding various clot characteristics and bleeding risk factors can help providers carefully manage acute venous thromboembolism.

Kara Morris, MSN, RN, OCN


Kara Morris and Christine Wylie on Oral Cryotherapy for Chemotherapy-Induced Mucositis in Breast Cancer

Kara Morris, MSN, RN, OCN; and Christine Wylie, MSN, RN, OCN, discuss the benefits of oral cryotherapy for patients receiving dose-dense doxorubicin.

Elizabeth Aronson, MSN, FNP-BCN, OCN


Elizabeth Aronson Breaks Down Data From Behind Talquetamab Approval in Multiple Myeloma

Elizabeth Aronson, MSN, FNP-BCN, OCN, shares what stood out to her about the phase 2 MonumenTAL-1 study assessing talquetamab in multiple myeloma.

Huntsman Cancer Institute at the University of Utah


Five Researchers Awarded Pilot Project Funding

Every year, Huntsman Cancer Institute receives funding from the American Cancer Society to support the promising research of junior faculty.

© 2023 MJH Life Sciences

All rights reserved.